Exchange: NASDAQ·Updated 03:50 PM EDT
HOWL logo

HOWL Werewolf Therapeutics Inc

$0.9821
$0.0191
(1.98%)
Today
EarningsOct 30
Mkt Cap$46.8M
Vol617,117.00

About HOWL

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.
40

Bearish Sentiment

How do you feel about HOWL?

SwingTrades1
$HOWL Make no mistake. I'm still calling $2.50. The short setup is getting fascinating: available shares to short have gone from just 65K to 3.8M, yet the borrow fee has surged from 5.24% to 17%. That tells you the supply of borrow has increased, but the demand to short remains extremely expensive. Now combine that with the options activity we've seen this past week. If the stock starts pushing higher, the shorts could find themselves in a very uncomfortable position very quickly.
14
BlindMonkey
$HOWL HOWL trading 240M shares isn’t retail —not even close. Retail can’t push that kind of volume even on its best day. This is MMs, algos, dark pools, and institutions rotating inventory after a MAJOR merger event. $150M institutional financing = funds repositioning. Phase 3 drug = biotech algos engaged. Merger halt = liquidity shock. When you see 240M+ volume with tight price action, that’s market makers pinning the tape and algos recycling shares, not retail “pumping” anything. HOWL is being traded by big players, not random traders. Understand the mechanics or you’ll misread the entire move. HOWL is still very much in play.
14
longshot45
$HOWL just picked up 5k more just under .85. I got time given it is worth .977 + 2 lotto tickets. No clue why someone would be inclined to short at these prices after the deal has been announced and the borrow cost spiked
12
Modo6177
$HOWL will re enter Monday. Nice catalyst and gap up into consolidation. This one has the potential to become big.
9
syzzz
$HOWL bought in at this price, trust me. This is not going up becUse I bought in. Would already be at 250% if I didnt buy. When I get Stoplossed out at .86 this will ho to 200%+ gains
1
5
AlertsAndNews
Let's look back at the highlights of the week here. Some great plays thats for sure. $HOWL $AMLX $AIXC $TNON $XOS to name a few. New plays next week. Link in bio for more! All trading and investing involves a risk of loss. Do your own due diligence always!
1
4
longshot45
$HOWL Two more weeks… when will we get the vote scheduled? What about the trial results? Hate the waiting game
1
Putanasaunders
$HOWL the road is open we just need some volym now !! And this will go to thw skyyy !!! !! Goooo Wolf !!
6
14kmaker
$HOWL we will see pre-market on Monday what the market makers think the price should be. My guess is that’s it’s a runner to 1.50
6
WilsonWorld
$HOWL 14 mil volume candle 12-1p cat tight fat GREEN. That’s VERY RARE - could be the goat of Friday pms in a loooong time
1
3
zawojak
$HOWL There was a guy here, somewhere below who topped up to 1M shares last week below 0.40😳😳 Well done mate !!
6
Modo6177
$HOWL making quiet moves… A puppy whimper in the dark Will soon become a foreboding howl in the night.
5
Putanasaunders
$HOWL push it up !! Buy and hodl lads !! I think if we break 1.04 again it will squeeze !! This should be atleast 3 dollars !! Great buy !! Phase 3 !
5
SCSyndrome
$HOWL Unlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term. The upgrade of Werewolf Therapeutics to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term. Holding.
5
SwingTrades1
$HOWL The MMs are putting on quite a show. Run it up to trigger the shorts, then sweep it back down to harvest the stops. Shake both sides of the tree and collect the liquidity. 😏
5
SwingTrades1
$HOWL If you think a freight train carrying $150 million is a scam, by all means, stand in front of it and short it while ignoring the growing list of partners lining up to do business with the company. 😏
5
Mr_Stochastic
$HOWL hehe big money. Ah well at least it's green. Holding turds over weekend you never know.
1
1
Putanasaunders
$HOWL only retardos selling off !! Im waiting for the opening to doubble my shares !! This will be great thoose levels are nothing some pennys only... Phase 3 and so cheap !!
4
NewNewOld
$HOWL if i understand right. AMBROS $125 million Series A and howl 47mil. and total value 500M when they listed if merge going through. it means 2,9x
1
1
JFais
$HOWL (NP) Reverse merger + $150M private placement From shell company to phase 3 with BTD and potential first FDA-approved treatment for CRPS-1 (65,000 newly diagnosed patients in the US annually, no approved therapies). Readout early 2028 Important safety derisking given neridronate administered to 600k patients in Italy across multiple bone diseases (essentially a better bisphosphonate)
4

Advertisement|Remove ads.